The chemical class known as β-defensin 124 (DEFB124) inhibitors encompasses a range of compounds that have the capacity to downregulate the expression or activity of β-defensin 124, a peptide involved in the innate immune response. These inhibitors can exert their effects through various mechanisms, such as modulation of inflammatory pathways, suppression of immune responses, or alteration of signaling pathways that are crucial for the synthesis and function of β-defensin 124. This chemical class is diverse, including molecules that interact with nuclear receptors to molecules that affect intracellular signaling cascades. For instance, some members of this class can interact with glucocorticoid receptors, which, upon activation, can translocate to the cell nucleus and bind to DNA response elements that regulate gene expression, including the genes responsible for the production of β-defensin 124. Others can influence the activity of transcription factors like NF-κB, which plays a significant role in the regulation of immune response genes.
In addition to their impact on gene expression, certain compounds within the β-defensin 124 inhibitor class can alter cellular signaling pathways, leading to a decrease in the synthesis of β-defensin 124. This can occur through the inhibition of kinases involved in signaling cascades that ultimately control the production and secretion of β-defensin 124. Some inhibitors may also interact with cell membrane receptors, affecting the downstream signaling required for β-defensin 124 expression. Moreover, this class includes compounds that can modify the external cellular environment, thereby influencing the conditions necessary for optimal β-defensin 124 function. As a part of the innate immune system, the regulation of β-defensin 124 by these inhibitors can have significant effects on the homeostasis of epithelial surfaces where these peptides play a protective role. Collectively, the compounds classified as β-defensin 124 inhibitors can vary widely in their structure and mode of action, but they share the commonality of being able to modulate the expression or activity of β-defensin 124, which is pivotal in the host defense mechanism.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
An immunosuppressant that could possibly inhibit DEFB124 by reducing the expression of antimicrobial peptides. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
A corticosteroid that could possibly inhibit DEFB124 by suppressing the NF-κB pathway. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
A synthetic glucocorticoid that could possibly inhibit DEFB124 by suppressing immune responses. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $62.00 $92.00 $265.00 $409.00 $622.00 | 6 | |
An antibiotic that could possibly inhibit DEFB124 as a secondary effect of its antimicrobial activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A metabolite of vitamin A that could possibly inhibit DEFB124 by modulating immune responses. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $41.00 | 4 | |
Can modulate inflammatory pathways and could possibly inhibit DEFB124 expression. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $52.00 $86.00 | 6 | |
A nonsteroidal anti-inflammatory drug (NSAID) that could possibly inhibit the expression of immune-related proteins, including DEFB124. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that could possibly inhibit DEFB124 by suppressing the immune system. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Known to modulate immune responses and could possibly inhibit DEFB124 production. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
An antimetabolite that could possibly inhibit DEFB124 by suppressing the immune system. | ||||||